AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported financial results for the fourth quarter and year ended December 31, 2024, and provided a business update.

AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics.

Anaptys Logo.png. Format PNG. Source AnaptysBio, Inc. Downloads. Original Large Medium Small About Us. GlobeNewswire is one of the world's largest newswire distribution networks, specializing in ...

Find the AnaptysBio style guide with brand assets such as logos, colors, fonts, and more.

Anaptys is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics for autoimmune and inflammatory diseases.

AnaptysBio ($ANAB) is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing innovative immunology therapeutics.

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.

AnaptysBio is a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics.

6 days ago · ANAB | Complete AnaptysBio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

AnaptysBio, Inc. 10770 Wateridge Circle Suite 210 San Diego, CA 92121-5801 (858) 362-6295 (ph) [email protected]